Molecular targets for altering radiosensitivity: lessons from Ras as a pre-clinical and clinical model.
Ras activation has been correlated with malignant and metastatic cancer phenotypes and poor prognosis for cancer patients. In the preclinical setting, Ras activation by mutation or EGFR amplification results in increased clonogenic cell survival and decreased tumor growth delay following irradiation...
Үндсэн зохиолчид: | Cengel, K, Mckenna, W |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2005
|
Ижил төстэй зүйлс
-
Molecular radiosensitization of pancreatic carcinoma cell lines in vivo and in vitro
-н: Cengel, K, зэрэг
Хэвлэсэн: (2004) -
The influence of Ras pathway signaling on tumor radiosensitivity.
-н: Kim, I, зэрэг
Хэвлэсэн: (2004) -
Modifying radiosensitivity in tumors: Targeting the Ras-PI-3 kinase pathway.
-н: Muschel, R, зэрэг
Хэвлэсэн: (2001) -
The clinical implications of gemcitabine radiosensitization.
-н: Doyle, T, зэрэг
Хэвлэсэн: (2001) -
Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.
-н: Kim, I, зэрэг
Хэвлэсэн: (2005)